Table 2

 Leptin expression in colorectal cancer and clinicopathological characteristics of patients

Clinicopathological featuresLeptin expressionp-Value
01+2+
n = 81n = 56n = 29
n*, number of cases taken as 100%.
Adc, adenocarcinoma; Adc muc, adenocarcinoma mucinosum.
Age (years)
    ⩽60 (n* = 52)25 (48.1%)16 (30.8%)11 (21.1%)0.672
    >60 (n* = 114)56 (49.1%)40 (35.1%)18 (15.8%)
Gender
    Male (n* = 88)41 (46.6%)33 (37.5%)14 (15.9%)0.539
    Female (n* = 78)40 (51.3%)23 (29.5%)15 (19.2%)
Tumour localisation
    Rectum (n* = 79)38 (48.2%)26 (32.9%)15 (18.9%)0.885
    Colon (n = 87; 100%)43 (49.4%)30 (34.5%)14 (16.1%)
Histological type
    Adc (n* = 141)66 (46.8%)46 (32.6%)29 (20.6%)0.044
    Adc muc (n* = 25)15 (60.0%)10 (40.0%)0 (0%)
Histological differentiation
    G2 (n* = 118)51 (43.2%)39 (33.1%)28 (23.7%)0.002
    G3 (n* = 48)30 (62.5%)17 (35.4%)1 (2.1%)
Tumour size
    pT1+pT2 (n* = 17)7 (41.2%)7 (41.2%)3 (17.6%)0.764
    pT3+pT4 (n* = 149)74 (49.7%)49 (32.9%)26 (17.4%)
Lymph node involvement
    Negative (n* = 82)40 (48.8%)26 (31.7%)16 (19.5%)0.746
    Positive (n* = 84)41 (48.8%)30 (35.7%)13 (15.5%)